"Arginine Vasopressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.
| Descriptor ID |
D001127
|
| MeSH Number(s) |
D06.472.699.631.692.781.100 D12.644.400.900.100 D12.644.456.925.100 D12.644.548.691.692.781.100 D12.776.631.650.937.100
|
| Concept/Terms |
Arginine Vasopressin- Arginine Vasopressin
- Argipressin
- Arg-Vasopressin
- Arg Vasopressin
- Vasopressin, Arginine
|
Below are MeSH descriptors whose meaning is more general than "Arginine Vasopressin".
Below are MeSH descriptors whose meaning is more specific than "Arginine Vasopressin".
This graph shows the total number of publications written about "Arginine Vasopressin" by people in this website by year, and whether "Arginine Vasopressin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2007 | 2 | 1 | 3 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2019 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arginine Vasopressin" by people in Profiles.
-
Bittman EL. Circadian Function in Multiple Cell Types Is Necessary for Proper Timing of the Preovulatory LH Surge. J Biol Rhythms. 2019 12; 34(6):622-633.
-
Rajhans P, Goin-Kochel RP, Strathearn L, Kim S. It takes two! Exploring sex differences in parenting neurobiology and behaviour. J Neuroendocrinol. 2019 09; 31(9):e12721.
-
Cuadra AE, Custer EE, Bosworth EL, Lemos JR. P2X7 receptors in neurohypophysial terminals: evidence for their role in arginine-vasopressin secretion. J Cell Physiol. 2014 Mar; 229(3):333-42.
-
Pietrzykowski AZ, Ortiz-Miranda S, Knott TK, Custer E, Puig S, Lemos JR, Treistman SN. Molecular tolerance of voltage-gated calcium channels is evident after short exposures to alcohol in vasopressin-releasing nerve terminals. Alcohol Clin Exp Res. 2013 Jun; 37(6):933-40.
-
Custer EE, Knott TK, Cuadra AE, Ortiz-Miranda S, Lemos JR. P2X purinergic receptor knockout mice reveal endogenous ATP modulation of both vasopressin and oxytocin release from the intact neurohypophysis. J Neuroendocrinol. 2012 Apr; 24(4):674-80.
-
Ortiz-Miranda SI, Dayanithi G, Vel?zquez-Marrero C, Custer EE, Treistman SN, Lemos JR. Differential modulation of N-type calcium channels by micro-opioid receptors in oxytocinergic versus vasopressinergic neurohypophysial terminals. J Cell Physiol. 2010 Oct; 225(1):276-88.
-
Knott TK, Marrero HG, Custer EE, Lemos JR. Endogenous ATP potentiates only vasopressin secretion from neurohypophysial terminals. J Cell Physiol. 2008 Oct; 217(1):155-61.
-
Handa RJ, Zoeller RT, McGivern RF. Changes in vasoactive intestinal peptide and arginine vasopressin expression in the suprachiasmatic nucleus of the rat brain following footshock stress. Neurosci Lett. 2007 Sep 25; 425(2):99-104.
-
Custer EE, Ortiz-Miranda S, Knott TK, Rawson R, Elvey C, Lee RH, Lemos JR. Identification of the neuropeptide content of individual rat neurohypophysial terminals. J Neurosci Methods. 2007 Jul 30; 163(2):226-34.
-
Muehlschlegel S, Dunser MW, Gabrielli A, Wenzel V, Layon AJ. Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage. Neurocrit Care. 2007; 6(1):3-10.